An observational study comparing efficacy and safety of warfarin brands in cardiovascular patients

Not Applicable

• Conditions: Atrial fibrillation; Venous thrombosis; Pulmonary embolism; Recurrent emboli; Prosthetic valve replacement; Acute myocardial infarction (to prevent systemic embolism); Cardiovascular - Other cardiovascular diseases

• Registration Number: ACTRN12613000703707
• Lead Sponsor: Therapeutcs Research Centre, University of South Australia

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2013-06-27
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 300

Inclusion Criteria

1. Age greater than or equal to 18 years
2. Receiving warfarin treatment

Exclusion Criteria

1. Age less than 18 years
2. Pregnancy or breast feeding
3. Non-adherence tendency
4. Psychiatric disorder or dementia
5. Taking any medications, food or dietary supplement that significantly interact with warfarin
6. Limited English communication proficiency

Study & Design

• Study Type: Observational
• Study Design: Not specified